Development of a densitometric method for the simultaneous estimation of antidiabetic drugs metformin and evogliptin

Deepanti Gajjar; Dimalkumar A. Shah

doi:10.1007/s00764-025-00395-3

January 17, 2026JPC - Journal of Planar Chromatography - Modern TLC

Development of a densitometric method for the simultaneous estimation of antidiabetic drugs metformin and evogliptin

View at Publisher

Ask AI

Bookmark

Share

Key Points

Antidiabetic drugs metformin and evogliptin can be effectively estimated using a new densitometric method.
This method achieves simultaneous estimation with high accuracy, enhancing the evaluation of diabetes management.
The developed method is validated through various analytical techniques, ensuring reliability in results.
This work highlights the potential for improved diabetes monitoring using a more efficient estimation method.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Development of a densitometric method enables simultaneous estimation of antidiabetic drugs in various samples, suggesting improved monitoring of diabetes treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gajjar et al. (2026) studied this question.

synapsesocial.com/papers/69a75a18c6e9836116a1fa02 https://doi.org/10.1007/s00764-025-00395-3

View at Publisher

Ask AI

Bookmark

Share

Development of a densitometric method for the simultaneous estimation of antidiabetic drugs metformin and evogliptin

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Development of a densitometric method for the simultaneous estimation of antidiabetic drugs metformin and evogliptin

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

More from JPC - Journal of Planar Chromatography - Modern TLC

Keep reading

More from JPC - Journal of Planar Chromatography - Modern TLC